Evidence map›Paper›PMID 40221975›Full record

ArticleJournal of Huntington's disease2025

Asymmetric brain atrophy in Huntington's disease: A postmortem MRI study.

Eardi Lila, David Hunt, Daniel D Child, Caitlin Latimer, Bianca Le, Marie Davis, Suman Jayadev, Thomas D Bird, Ali Shojaie, Christine L Mac Donald

Abstract read
In one paragraph

Article in Journal of Huntington's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eardi LilaDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
David HuntDepartment of Neurological Surgery, University of Washington, Seattle, WA, USA.ORCID 0000-0003-0590-874X
Daniel D ChildDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.ORCID 0000-0002-4309-0144
Caitlin LatimerDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.ORCID 0000-0003-3727-4278
Bianca LeDepartment of Neurology, University of Washington, Seattle, WA, USA.
Marie DavisDepartment of Neurology, University of Washington, Seattle, WA, USA.ORCID 0000-0003-2502-6293
Suman JayadevDepartment of Neurology, University of Washington, Seattle, WA, USA.
Thomas D BirdDepartment of Neurology, University of Washington, Seattle, WA, USA.
Ali ShojaieDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Christine L Mac DonaldDepartment of Neurological Surgery, University of Washington, Seattle, WA, USA.ORCID 0000-0002-7419-996X

Funding

XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI Sheela Sathyanarayana · 1995 to 2026
$42.5M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Thomas J. Grabowski · 2020 to 2026
$29.0M
Statistical models for the integrative analysis of complex biomedical images with manifold structureR03EB033001 · NIBIB · UNIVERSITY OF WASHINGTON · PI LILA, EARDI · 2023 to 2024
$151k
NIA NIH HHS P30 AG066509NIBIB NIH HHS R03 EB033001NIEHS NIH HHS P30 ES007033
6 · The paper itself

Abstract

BackgroundHuntington's disease is a progressive, autosomal dominant, neurodegenerative disease caused by a CAG repeat expansion in the HTT gene. Medium spiny neurons of the striatum are especially vulnerable to the disease, and atrophy of the caudate and putamen can be documented by neuroimaging years before the onset of symptoms.ObjectiveIn this study, we aimed to characterize region-specific gray and white matter differences between Huntington's disease patients and controls.MethodsWe conducted a postmortem MRI study of the brains of 15 adults diagnosed with symptomatic Huntington's disease and 26 control subjects, aiming to compare the differences in regional grey and white matter volumes between the two groups.ResultsThe study revealed decreased volumes in both grey and white matter in patients with Huntington's disease, with the largest effect sizes observed in caudate and putamen. Notably, the atrophy predominantly affected the left hemisphere, particularly impacting grey and white matter regions adjacent to the pars opercularis, precentral, supramarginal, and pars orbitalis gyri, and the lateral orbitofrontal cortex. In the control group, asymmetry stems from larger left hemisphere regions compared to right, whereas an opposite pattern is observed in the Huntington's disease group.ConclusionsThese results suggest progressive, diffuse, and asymmetric grey and white matter atrophy occurs in Huntington's disease. The reasons for this asymmetry remain unknown; however, our study provides a more detailed characterization of previously reported grey and white matter changes in Huntington's disease, as observed through postmortem histopathological and MRI studies.

Indexed as

BrainGray MatterHuntington DiseaseWhite MatterAdultAgedAtrophyAutopsyFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPostmortem ImagingPutamenasymmetryatrophyHuntington's diseaseMRI

Identifiers

PMID40221975
PMCPMC12419748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.